Cyteir Therapeutics Inc (CYT) Form 4 Filed by Venrock Associates VII, L.P. and 2 Others, Jun 23, 2021

SEC Form 4 · No Market Transaction
Conversion

Conversion of derivative securities.

Reporting Owners
TXN 2021-06-22 · FILED 2021-06-23
Equity Position 3.26M sh 0 → 3,259,025
Filing Lag 1 business day within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2021-06-23
Report Date
2021-06-22
Accession No.
0001209191-21-042724
Accepted At
2021-06-23 16:08 UTC
Reporting Owners
Name Relationship
Venrock Associates VII, L.P. CIK 0001614766
10% Owner
Venrock Partners VII, L.P. CIK 0001614765
10% Owner
Venrock Management VII, LLC CIK 0001614686
10% Owner
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common StockF1F2 2021-06-22 C - Conversion 3,259,025 A — 3,259,025 Indirect
Derivative Securities Transactions
Title Strike Date Type Shares Price Expiration Underlying Ownership
Series B Convertible Preferred StockF1F1F1F1 2021-06-22 C - Conversion 10,000,000 D 2,933,583 Common Stock Direct
Series C Convertible Preferred StockF1F1F1F1 2021-06-22 C - Conversion 1,109,368 D 325,442 Common Stock Direct
Footnotes (2)
F1
Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 1:3.4088 upon completion of the Issuer's initial public offering. The shares have no expiration date. Show more
F2
Consists of 3,009,710 shares of Common Stock held by Venrock Associates VII, L.P. ("VA VII") and 249,315 shares of Common Stock held by Venrock Partners VII, L.P. ("VP VII"). Venrock Management VII, LLC ("VM VII") is the sole general partner of VA VII and VP VII and may be deemed to beneficially own these shares and expressly disclaims beneficial ownership over all shares held by VA VII and VP VII except to the extent of its indirect pecuniary interest therein. Show more
Other insiders at Cyteir Therapeutics Inc
All Cyteir Therapeutics Inc insider activity
GET /v1/forms/4/0001209191-21-042724 API docs
View Original SEC Filing